Market closed
GoodRx/$GDRX
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About GoodRx
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
Ticker
$GDRX
Sector
Trading on
Industry
Health Care Technology
Headquarters
Employees
694
Website
GoodRx Metrics
BasicAdvanced
$1.9B
Market cap
-
P/E ratio
-$0.05
EPS
1.39
Beta
-
Dividend rate
Price and volume
Market cap
$1.9B
Beta
1.39
52-week high
$9.26
52-week low
$4.09
Average daily volume
1.8M
Financial strength
Current ratio
5.481
Quick ratio
4.849
Long term debt to equity
76.859
Total debt to equity
78.194
Interest coverage (TTM)
1.58%
Management effectiveness
Return on assets (TTM)
4.34%
Return on equity (TTM)
-2.06%
Valuation
Price to revenue (TTM)
2.427
Price to book
2.69
Price to tangible book (TTM)
16.77
Price to free cash flow (TTM)
21.693
Growth
Revenue change (TTM)
7.14%
Earnings per share change (TTM)
-247.38%
3-year revenue growth (CAGR)
4.85%
3-year earnings per share growth (CAGR)
-59.86%
What the Analysts think about GoodRx
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for GoodRx stock.
GoodRx Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
GoodRx Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
GoodRx News
AllArticlesVideos
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
CNBC·6 days ago
GoodRx Helps Announces Recipients of 2024 Students for Healthcare Equity Scholarship
Business Wire·3 weeks ago
GOODRX ALERT: Bragar Eagel & Squire, P.C. is Investigating GoodRx Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
GlobeNewsWire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for GoodRx stock?
GoodRx (GDRX) has a market cap of $1.9B as of December 12, 2024.
What is the P/E ratio for GoodRx stock?
The price to earnings (P/E) ratio for GoodRx (GDRX) stock is 0 as of December 12, 2024.
Does GoodRx stock pay dividends?
No, GoodRx (GDRX) stock does not pay dividends to its shareholders as of December 12, 2024.
When is the next GoodRx dividend payment date?
GoodRx (GDRX) stock does not pay dividends to its shareholders.
What is the beta indicator for GoodRx?
GoodRx (GDRX) has a beta rating of 1.39. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.